Dr Shezad Malik Law Firm is investigating NuvaRing Lawsuit Claims due to side effects that may include blood clots, Deep Vein Thrombosis, Pulmonary Embolism, Heart Attacks, Strokes, and Wrongful Death.
Read our latest filed NuvaRing lawsuit here. We have many more NuvaRing lawsuits in the preparation phase for filing.
Dr Shezad Malik law firm is a national law firm focused on fighting for the rights of serious personal injury victims. We are announcing the launch of an investigation into alleged NuvaRing side effects.
We are evaluating the following alleged NuvaRing Injuries:
Deep Vein Thrombosis (DVT),
Heart Attack or Myocardial Infarction,
There is still time for young women who may have been injured by NuvaRing side effects, or their families, to file their own lawsuits against Merck and Organon.
To discuss a potential lawsuit claim, please contact us at 1-888-210-9693 or visit our website.
What is NuvaRing?
NuvaRing is a hormonal contraceptive device that releases a combination of etonogestrel, a synthetic generation progestin, and the estrogen, ethinyl estradiol.
NuvaRing is a small flexible ring that is designed to be inserted into the vagina once a month. It is kept in place for three weeks, and prevents pregnancy by releasing controlled amounts of those hormones into the bloodstream.
NuvaRing is marketed by Merck & Co.’s Organon subsidiary, NuvaRing was introduced to the U.S. marketplace in 2001.
Etonogestrel is a form of desogestrel, a third-generation progestin. In February 2007, the consumer advocacy group Public Citizen petitioned the U.S. Food & Drug Administration (FDA) to ban oral birth control pills that contain desogestrel, citing studies which indicated they could double the risk of blood clots compared to second generation oral contraceptives.
In 2007, the consumer advocacy group Public Citizen asked the FDA to ban oral contraceptives that contained forms of desogestral because this dangerous progestin has been implicated in a higher risk of strokes, blood clots and other cardiovascular problems.
NuvaRing releases approximately 120 micrograms of etonogestral – an active desogestral metabolite – per day, a relatively high dose of this dangerous hormone. The NuvaRing injury lawyers at our firm believe this high dose of etonogestral is responsible for the high number of cardiac side effects reports associated with NuvaRing.
In August 2008, the Judicial Panel on Multidistrict Litigation (JPML) ordered all federally filed NuvaRing lawsuits to be consolidated in a multidistrict litigation and transferred to Judge Rodney W. Sippel of the U.S. District Court, Eastern District of Missouri.
The lawsuits allege that Merck & Co. and Organon failed to adequately warn patients and their doctors about the potential for NuvaRing blood clots, deep vein thrombosis, pulmonary embolism, heart attacks, strokes and sudden death because of the device.
File Your Lawsuit Now
There is still time for young women who may have been injured by NuvaRing, or their families, to file their own lawsuits against Merck and Organon. To discuss a potential claim, please contact us at 1-888-210-9693 or visit our website.